- Home
- EVTC vs NVCR Comparison
EVTC vs NVCR Comparison
Compare EVTC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVTC
- NVCR
- Stock Information
- Founded
- EVTC 1988
- NVCR 2000
- Country
- EVTC United States
- NVCR Switzerland
- Employees
- EVTC N/A
- NVCR N/A
- Industry
- EVTC EDP Services
- NVCR Medical/Dental Instruments
- Sector
- EVTC Technology
- NVCR Health Care
- Exchange
- EVTC Nasdaq
- NVCR Nasdaq
- Market Cap
- EVTC 2.3B
- NVCR 1.9B
- IPO Year
- EVTC 2013
- NVCR 2015
- Fundamental
- Price
- EVTC $33.49
- NVCR $16.06
- Analyst Decision
- EVTC Hold
- NVCR Buy
- Analyst Count
- EVTC 5
- NVCR 7
- Target Price
- EVTC $39.00
- NVCR $32.43
- AVG Volume (30 Days)
- EVTC 336.8K
- NVCR 1.2M
- Earning Date
- EVTC 07-30-2025
- NVCR 07-24-2025
- Dividend Yield
- EVTC 0.60%
- NVCR N/A
- EPS Growth
- EVTC 101.39
- NVCR N/A
- EPS
- EVTC 2.00
- NVCR N/A
- Revenue
- EVTC $868,960,000.00
- NVCR $621,711,000.00
- Revenue This Year
- EVTC $7.88
- NVCR $5.44
- Revenue Next Year
- EVTC $4.98
- NVCR $9.05
- P/E Ratio
- EVTC $16.75
- NVCR N/A
- Revenue Growth
- EVTC 17.39
- NVCR 18.27
- 52 Week Low
- EVTC $31.11
- NVCR $14.17
- 52 Week High
- EVTC $38.56
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- EVTC 37.01
- NVCR 42.07
- Support Level
- EVTC $32.85
- NVCR $16.10
- Resistance Level
- EVTC $34.02
- NVCR $18.59
- Average True Range (ATR)
- EVTC 0.84
- NVCR 0.70
- MACD
- EVTC -0.31
- NVCR -0.14
- Stochastic Oscillator
- EVTC 20.49
- NVCR 13.46
About EVTC Evertec Inc.
Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions which derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. It derives maximum revenue from Latin America Payments and Solutions. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.